business
AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics
Buyout comes amid an uptick in biotech dealmaking as Big Pharma seeks to bolster its drug pipelines
Read full story on Financial Times → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Financial Times alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop